HOME >> BIOLOGY >> NEWS
Scientific publications: Time for change

Changes in scientific publishing are "necessary as a matter of urgency" and everyone should have free, open access to UK research findings. So says the UK House of Commons Science & Technology Committee in their report on scientific publishing, published today.

Vitek Tracz, Chairman of the Open Access publisher BioMed Central said: "We welcome this important and forward-looking report which marks the beginning of a new era. Change is essential for science and will benefit society."

Crucially, the report recommends that UK research funding bodies mandate free access to all their research findings. "This will lead to a profound change in the way that scientific literature is published, and validates the author-pays 'Open Access' publishing model which we at BioMed Central pioneered," Tracz remarked.

The Committee urge the UK Government to "act as a proponent for change" and "lead by example".

Some UK funders have already shown great support for the Open Access publishing model. By signing agreements with BioMed Central, JISC and NHS England have made it possible for many UK researchers to publish free of charge in Open Access journals.

The Committee recommends that UK Research Councils follow this lead and make funds available to pay author charges. This would mean that all publicly funded UK researchers would be able to make their research findings Open Access, at no cost to themselves. "This support will help to ensure the success of the author-pays model of publishing," said Tracz.

To improve access to research findings in the short term, the Committee have called for all UK higher education institutions to "establish institutional repositories on which their published output can be stored and from which it can be read, free of charge, online". In addition, they ask Research Councils to "mandate their funded researchers to deposit a copy of all their articles in their institutional repository [] as a condition of
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-631-9931
BioMed Central
20-Jul-2004


Page: 1 2

Related biology news :

1. 2nd media alert First Scientific Conference on Childhood Leukaemia
2. First International Scientific Conference on Childhood Leukaemia
3. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award
4. Press briefings at The Gerontological Society of Americas 56th Annual Scientific Meeting
5. Scientific study of twins shows forgiveness has genetic component
6. Scientific equipment including the first European student experiment reaches the ISS
7. Emorys CancerQuest wins top Web award from Scientific American
8. Scientific innovations, social issues and biobusiness at Bio Tech Helsinki 03
9. Scientific balancing act dominates AAAS top ten list of science policy stories for 2002
10. Acorda Therapeutics receives L.W. Freeman Award for Scientific Research
11. Scientific bias helping cause mass extinction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientific publications Time for change

(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/14/2015)... YORK , May 14, 2015 /PRNewswire/ ... in identity verification and online remote proctoring, ... a software-as-a-service (SaaS) company and creator of ... customers of the two companies will benefit ... in Canvas. As a fully ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
(Date:5/28/2015)... May 28, 2015 Biscayne Pharmaceuticals, Inc ... of its growth hormone-releasing hormone (GHRH) technology will be discussed ... ASCO Annual Meeting. The data show that the family ... GHRH blockers, is present on many primary breast cancer ... that GHRH antagonists could have broad anti-cancer potential in ...
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo ... EMR/EHR Clinical Data Integration with EDC Systems ” at ... DC on June 14th-18th. , During the presentation, Glenn ... with EDC, and will examine the value of patient ... electronic health records/electronic medical records integration. , The ...
(Date:5/28/2015)... May 28, 2015 Dr. Carl ... today that Roger L. Williams, MD, has joined ... Partners Premier Experts are top tier consultants whose ... extraordinary value to the company’s clients. Premier Experts ... help clients successfully develop their medical products, pursue ...
(Date:5/27/2015)... RXi Pharmaceuticals Corporation (NASDAQ: RXII ... developing innovative therapies primarily in the areas of ... a public offering of shares of its common ... stock and overallotment purchase rights to purchase shares ... stock, warrants and overallotment purchase rights are immediately ...
Breaking Biology Technology:Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3
Cached News: